XML 289 R94.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Note 12 - Share-based payments - Inputs for Measurement of Grant Date Fair Values and Share Units Granted (Details) |  |  | 12 Months Ended
--- | --- | --- | ---
Apr. 07, 2023 USD ($) $ / shares | Jan. 24, 2022 USD ($) $ / shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares
Restricted stock units (RSUs) [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Risk free rate |  |  | 0.00% | 3.88%
Fair value (USD) | $ |  |  | $ 0 | $ 12.52
Share price (USD) (in dollars per share) | $ / shares |  |  | $ 0 | $ 12.4
Volatility |  |  | 0.00% | 1.29%
RSU dividends reinvested |  |  | 1,980 | 1,980
Settlements/terminations |  |  | (19,565) | 0
Total awards outstanding |  |  | 0 | 19,565
Restricted stock units (RSUs) [member] | January 11, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | March 23, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 8, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | January 11, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 17,585 | 17,585
Restricted stock units (RSUs) [member] | March 31, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 1, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 9, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 14, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | October 5, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | January 11, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | April 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | May 14, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 14, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | August 13, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 6, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 20, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | October 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | October 11, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | November 12, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | December 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | January 11, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | January 12, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | May 13, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | July 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | October 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | April 7, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | May 15, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 1, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | June 7, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | August 10, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | September 1, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Restricted stock units (RSUs) [member] | October 3, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 0
Performance share units (PSUs) [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Risk free rate |  |  | 3.88% | 3.88%
Fair value (USD) | $ |  |  | $ 12.2 | $ 12.42
Share price (USD) (in dollars per share) | $ / shares |  |  | $ 12.2 | $ 12.42
Volatility |  |  | 0.90% | 0.91%
RSU dividends reinvested |  |  | 0 | 0
Settlements/terminations |  |  | (144,772) | (254,491)
Total awards outstanding |  |  | 182,314 | 224,408
Performance share units (PSUs) [member] | Bottom of range [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Performance multiplier percentage |  |  | 93.00% | 93.00%
Performance share units (PSUs) [member] | Top of range [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Performance multiplier percentage |  |  | 100.00% | 100.00%
Performance share units (PSUs) [member] | January 11, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 95,740
Performance share units (PSUs) [member] | March 23, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 28,287
Performance share units (PSUs) [member] | June 8, 2019 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 14,672
Performance share units (PSUs) [member] | January 11, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 69,678 | 114,668
Performance share units (PSUs) [member] | March 31, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 696 | 1,971
Performance share units (PSUs) [member] | June 1, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 1,740
Performance share units (PSUs) [member] | September 9, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 697 | 1,611
Performance share units (PSUs) [member] | September 14, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 5,300 | 20,686
Performance share units (PSUs) [member] | October 5, 2020 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 230 | 514
Performance share units (PSUs) [member] | January 11, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 56,244 | 78,875
Performance share units (PSUs) [member] | April 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 770
Performance share units (PSUs) [member] | May 14, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 964 | 2,389
Performance share units (PSUs) [member] | June 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 1,310 | 1,692
Performance share units (PSUs) [member] | June 14, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 398 | 507
Performance share units (PSUs) [member] | August 13, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 2,283
Performance share units (PSUs) [member] | September 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 0 | 553
Performance share units (PSUs) [member] | September 6, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 458 | 531
Performance share units (PSUs) [member] | September 20, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 460 | 526
Performance share units (PSUs) [member] | October 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 1,016 | 2,530
Performance share units (PSUs) [member] | October 11, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 450 | 500
Performance share units (PSUs) [member] | November 12, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 1,846 | 1,998
Performance share units (PSUs) [member] | December 1, 2021 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 900 | 936
Performance share units (PSUs) [member] | January 11, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 75,198 | 96,359
Performance share units (PSUs) [member] | January 12, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 825 | 825
Performance share units (PSUs) [member] | May 13, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 2,040 | 2,040
Performance share units (PSUs) [member] | June 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 1,297 | 1,297
Performance share units (PSUs) [member] | July 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 2,375 | 2,375
Performance share units (PSUs) [member] | October 1, 2022 [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 2,024 | 2,024
Performance share units (PSUs) [member] | April 7, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 79,521 | 0
Performance share units (PSUs) [member] | May 15, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 581 | 0
Performance share units (PSUs) [member] | June 1, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 617 | 0
Performance share units (PSUs) [member] | June 7, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 572 | 0
Performance share units (PSUs) [member] | August 10, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 5,514 | 0
Performance share units (PSUs) [member] | September 1, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 1,617 | 0
Performance share units (PSUs) [member] | October 3, 2023 [Member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Grants |  |  | 14,258 | 0
Equity-settled performance units (EPUs) [member] |  |  |  |
Statement Line Items [Line Items] |  |  |  |
Fair value (USD) | $ | $ 15.33 | $ 10.15 |  |
Share price (USD) (in dollars per share) | $ / shares | $ 16.91 | $ 11.5 |  |
Performance multiplier percentage | 100.00% | 100.00% | 100.00% |
Total awards outstanding | 80,773 | 113,693 |  |

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement as a result of dividends being re-invested. + References No definition available. + Details
Name: | cmcl_NumberOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangementFromDividends
Namespace Prefix: | cmcl_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The performance multiplier if performance conditions have been met. + References No definition available. + Details
Name: | cmcl_PerformanceMultiplier
Namespace Prefix: | cmcl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cmcl_Statement1LineItems
Namespace Prefix: | cmcl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cmcl_RestrictedStockUnitsRsusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_January112019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_March232019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June82019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_January112020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_March312020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September92020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September142020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_October52020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_January112021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_April12021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_May142021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June12021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June142021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_August132021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September12021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September62021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September202021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_October12021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_October112021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_November122021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_December12021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_January112022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_January122022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_May132022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June12022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_July12022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_October12022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_April72023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_May152023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June12023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_June72023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_August102023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_September12023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreationDateAxis=cmcl_October32023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cmcl_PerformanceShareUnitsPsusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cmcl_EquitysettledPerformanceUnitsEpusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |